Hospice Registered Nurse

Ennoble Care welcomes Chief Managed Care Officer and General Counsel. World · OCT 14, 2026 PR Newswire Marc Hudak and Ashley Lunkenheimer bring decades of healthcare experience to support continued growth ARLINGTON, Va., Oct. 14, 2026 /PRNewswire/ - Ennobl... Marc Hudak and Ashley Lunkenheimer bring decades of healthcare experience to support continued growth ARLINGTON, Va., Oct. 14, 2026 /PRNewswire/ - Ennoble Care, a leading home-based primary, palliative, and hospice care provider, has welcomed two senior leaders to its executive team. Marc Hudak joins as Chief Managed Care Officer and President of Health Plans, overseeing the company's managed care strategy, and Ashley Lunkenheimer joins as General Counsel and Chief Compliance Officer, leading Ennoble Care's legal, regulatory, public policy, and compliance functions. Together, these hires will help Ennoble Care deepen partnerships and build the infrastructure needed to expand home-based care across the healthcare ecosystem. "Our patients are among the most medically complex in Medicare, and providing personalized, compassionate care for them in the comfort of their homes takes a seasoned team with an entrepreneurial mindset," said Kush Das, Co-Founder and Chief Executive Officer of Ennoble Care. "Marc and Ashley bring decades of experience and proven leadership in their fields, and we are excited to have them join our team in making a real difference in the lives of homebound patients." Hudak previously served as Chief Growth Officer at Longevity Health, where he helped scale a national value-based Medicare Advantage and senior living platform across more than 17 states. Earlier in his career, he held executive and transformational leadership roles at Evolent Health, Blue Cross & Blue Shield of Rhode Island, and Cigna, where he helped grow value-based care to more than 100 ACOs and led businesses serving hundreds of thousands of Medicare, Medicaid, and commercial members. He currently serves on the President's Council at Hope Health Hospice and Palliative Care as well as the Board of Trustees at Mason Preparatory School. Lunkenheimer joins Ennoble Care with nearly 25 years of legal experience spanning public service, healthcare law, and civic leadership. As a former federal prosecutor and healthcare attorney who has worked on both the payer and provider sides of the industry, she will lead Ennoble Care's complex legal, regulatory, and compliance functions. Lunkenheimer previously served as vice president and deputy general counsel at AmeriHealth Caritas and spent nearly a decade as an Assistant U.S. Attorney in the Eastern District of Pennsylvania, handling both criminal and civil healthcare cases. Beyond Ennoble Care, Lunkenheimer chairs the Delaware County Board of Elections and is a member of the Philadelphia Sisters, a group that has helped bring major women's professional sports initiatives to Philadelphia. These strategic hires come as Ennoble Care continues to expand its footprint and deliver strong patient outcomes. In September, the company announced its expansion into five new communities in Florida, Kentucky, Ohio, Mississippi, and Texas. In July, Ennoble Care released its 2026 Quality and Outcomes Report, which found that patients experienced 25 percent fewer hospitalizations in their first year of care and 63 percent fewer by their second year, while serving a patient population roughly twice as medically complex as the national Medicare average. About Ennoble Care Ennoble Care is a home-based primary, palliative, and hospice care provider serving high-need Medicare patients across 17 states. Through its proprietary electronic health record platform and value-based care model, the company delivers coordinated, multidisciplinary care each year to more than 50,000 patients where they live. Independently founded and led by clinician-entrepreneurs, Ennoble Care is focused on improving outcomes and expanding access for the nation's most medically complex seniors. For more information, visit ennoblecare.com. SOURCE Ennoble Care Published by News Desk · WeeklyReviewer The WeeklyReviewer news desk monitors breaking developments around the clock - sourcing, verifying, and publishing real-time industry news across business, technology, politics, science, sports, and world affairs. Every story that comes through the Live Wire is reviewed for accuracy before publication, keeping our readers ahead of the curve without the noise.

NVIDIA and CoreWeave deploy production AI infrastructure for agentic workloads. At the CoreWeave Fully Connected conference in San Francisco this week, NVIDIA and CoreWeave unveiled production-ready infrastructure designed to bridge the gap between AI model training and agentic deployment. The announcement centers on the immediate availability of NVIDIA Vera Rubin NVL72 systems paired with Spectrum-X 102.4T Ethernet networking on the CoreWeave Cloud platform. Cognition, the developer of the Devin AI software engineer, has been selected as the inaugural customer to run production inference workloads on the new architecture. Early benchmarking demonstrates that Vera Rubin delivers up to a 4.8x increase in total token throughput for complex SWE-2 coding tasks compared to the preceding GB200 NVL72 baseline, significantly accelerating real-time code generation and multistep reasoning. To support the computational demands of agentic AI, CoreWeave also introduced NVIDIA Vera, a CPU specifically engineered for high-concurrency agent environments. By housing 128 processors and 11,264 cores per rack, the system supports over 11,000 concurrent isolated agent environments. Integrated with CoreWeave Sandboxes and managed through Spectrum-X switches and BlueField-4 DPUs, the Vera CPU achieved more than a 3x improvement in sandbox startup times and a 1.7x performance gain on the Terminal-Bench evaluation suite, ensuring low-latency, secure communication across distributed agent workloads. Complementing the hardware rollout is CoreWeave Forge, a unified development environment designed to close the traditional divide between production telemetry and model refinement. Forge consolidates Weights & Biases, OpenPipe post-training capabilities, and the marimo notebook framework into a single workflow. The platform introduces CoreWeave ARIA for automated experiment analysis and code iteration, Agent Lens for production observability that reduces issue resolution costs by 50%, and serverless reinforcement learning capabilities that accelerate training by 1.4x while cutting costs by 40%. A newly private-previewed feature, RL Rollouts, leverages NVIDIA Dynamo to load model checkpoints into live deployments without service interruption, enabling continuous reinforcement learning alongside production inference. Enterprise adoption of the NVIDIA-CoreWeave stack is accelerating rapidly. Beyond Cognition, initial Forge users include Canva, Capital One, and MasterClass. In the healthcare sector, Ennoble Care has selected CoreWeave to deploy reserved NVIDIA RTX PRO 6000 GPU capacity for scaling clinical documentation agents across Medicare patient networks. The partnership maintains CoreWeave's position as the exclusive Platinum-ranked provider across SemiAnalysis ClusterMAX benchmarks and continues to serve nine of the top ten AI laboratories. By co-engineering infrastructure that scales from prototype deployment to continuous production feedback, NVIDIA and CoreWeave are establishing a standardized pipeline for transforming experimental AI agents into reliable, large-scale enterprise systems.